Copyright Reports & Markets. All rights reserved.

Global Personal Dosimetry Market Research Report 2021

Buy now

1 Personal Dosimetry Market Overview

  • 1.1 Product Overview and Scope of Personal Dosimetry
  • 1.2 Personal Dosimetry Segment by Type
    • 1.2.1 Global Personal Dosimetry Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 TLD
    • 1.2.3 OSL
    • 1.2.4 RPL
    • 1.2.5 Active Type
  • 1.3 Personal Dosimetry Segment by Application
    • 1.3.1 Global Personal Dosimetry Sales Comparison by Application: (2021-2027)
    • 1.3.2 Medical
    • 1.3.3 Scientific Research
    • 1.3.4 Industrial and Nuclear Plant
    • 1.3.5 Others
  • 1.4 Global Personal Dosimetry Market Size Estimates and Forecasts
    • 1.4.1 Global Personal Dosimetry Revenue 2016-2027
    • 1.4.2 Global Personal Dosimetry Sales 2016-2027
    • 1.4.3 Personal Dosimetry Market Size by Region: 2016 Versus 2021 Versus 2027

2 Personal Dosimetry Market Competition by Manufacturers

  • 2.1 Global Personal Dosimetry Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Personal Dosimetry Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Personal Dosimetry Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Personal Dosimetry Manufacturing Sites, Area Served, Product Type
  • 2.5 Personal Dosimetry Market Competitive Situation and Trends
    • 2.5.1 Personal Dosimetry Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Personal Dosimetry Players Market Share by Revenue
    • 2.5.3 Global Personal Dosimetry Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Personal Dosimetry Retrospective Market Scenario by Region

  • 3.1 Global Personal Dosimetry Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Personal Dosimetry Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Personal Dosimetry Market Facts & Figures by Country
    • 3.3.1 North America Personal Dosimetry Sales by Country
    • 3.3.2 North America Personal Dosimetry Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Personal Dosimetry Market Facts & Figures by Country
    • 3.4.1 Europe Personal Dosimetry Sales by Country
    • 3.4.2 Europe Personal Dosimetry Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Personal Dosimetry Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Personal Dosimetry Sales by Region
    • 3.5.2 Asia Pacific Personal Dosimetry Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Personal Dosimetry Market Facts & Figures by Country
    • 3.6.1 Latin America Personal Dosimetry Sales by Country
    • 3.6.2 Latin America Personal Dosimetry Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Personal Dosimetry Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Personal Dosimetry Sales by Country
    • 3.7.2 Middle East and Africa Personal Dosimetry Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Personal Dosimetry Historic Market Analysis by Type

  • 4.1 Global Personal Dosimetry Sales Market Share by Type (2016-2021)
  • 4.2 Global Personal Dosimetry Revenue Market Share by Type (2016-2021)
  • 4.3 Global Personal Dosimetry Price by Type (2016-2021)

5 Global Personal Dosimetry Historic Market Analysis by Application

  • 5.1 Global Personal Dosimetry Sales Market Share by Application (2016-2021)
  • 5.2 Global Personal Dosimetry Revenue Market Share by Application (2016-2021)
  • 5.3 Global Personal Dosimetry Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Landauer
    • 6.1.1 Landauer Corporation Information
    • 6.1.2 Landauer Description and Business Overview
    • 6.1.3 Landauer Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Landauer Personal Dosimetry Product Portfolio
    • 6.1.5 Landauer Recent Developments/Updates
  • 6.2 Chiyoda Technol Corporation
    • 6.2.1 Chiyoda Technol Corporation Corporation Information
    • 6.2.2 Chiyoda Technol Corporation Description and Business Overview
    • 6.2.3 Chiyoda Technol Corporation Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Chiyoda Technol Corporation Personal Dosimetry Product Portfolio
    • 6.2.5 Chiyoda Technol Corporation Recent Developments/Updates
  • 6.3 Mirion Technologies
    • 6.3.1 Mirion Technologies Corporation Information
    • 6.3.2 Mirion Technologies Description and Business Overview
    • 6.3.3 Mirion Technologies Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Mirion Technologies Personal Dosimetry Product Portfolio
    • 6.3.5 Mirion Technologies Recent Developments/Updates
  • 6.4 Thermo Fisher Scientific
    • 6.4.1 Thermo Fisher Scientific Corporation Information
    • 6.4.2 Thermo Fisher Scientific Description and Business Overview
    • 6.4.3 Thermo Fisher Scientific Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Thermo Fisher Scientific Personal Dosimetry Product Portfolio
    • 6.4.5 Thermo Fisher Scientific Recent Developments/Updates
  • 6.5 Fuji Electric
    • 6.5.1 Fuji Electric Corporation Information
    • 6.5.2 Fuji Electric Description and Business Overview
    • 6.5.3 Fuji Electric Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Fuji Electric Personal Dosimetry Product Portfolio
    • 6.5.5 Fuji Electric Recent Developments/Updates
  • 6.6 Hitachi Aloka
    • 6.6.1 Hitachi Aloka Corporation Information
    • 6.6.2 Hitachi Aloka Description and Business Overview
    • 6.6.3 Hitachi Aloka Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Hitachi Aloka Personal Dosimetry Product Portfolio
    • 6.6.5 Hitachi Aloka Recent Developments/Updates
  • 6.7 Bertin Instruments
    • 6.6.1 Bertin Instruments Corporation Information
    • 6.6.2 Bertin Instruments Description and Business Overview
    • 6.6.3 Bertin Instruments Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Bertin Instruments Personal Dosimetry Product Portfolio
    • 6.7.5 Bertin Instruments Recent Developments/Updates
  • 6.8 Tracerco
    • 6.8.1 Tracerco Corporation Information
    • 6.8.2 Tracerco Description and Business Overview
    • 6.8.3 Tracerco Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Tracerco Personal Dosimetry Product Portfolio
    • 6.8.5 Tracerco Recent Developments/Updates
  • 6.9 ATOMTEX
    • 6.9.1 ATOMTEX Corporation Information
    • 6.9.2 ATOMTEX Description and Business Overview
    • 6.9.3 ATOMTEX Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 ATOMTEX Personal Dosimetry Product Portfolio
    • 6.9.5 ATOMTEX Recent Developments/Updates
  • 6.10 Ludlum Measurements
    • 6.10.1 Ludlum Measurements Corporation Information
    • 6.10.2 Ludlum Measurements Description and Business Overview
    • 6.10.3 Ludlum Measurements Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Ludlum Measurements Personal Dosimetry Product Portfolio
    • 6.10.5 Ludlum Measurements Recent Developments/Updates
  • 6.11 XZ LAB
    • 6.11.1 XZ LAB Corporation Information
    • 6.11.2 XZ LAB Personal Dosimetry Description and Business Overview
    • 6.11.3 XZ LAB Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 XZ LAB Personal Dosimetry Product Portfolio
    • 6.11.5 XZ LAB Recent Developments/Updates
  • 6.12 Arrow-Tech
    • 6.12.1 Arrow-Tech Corporation Information
    • 6.12.2 Arrow-Tech Personal Dosimetry Description and Business Overview
    • 6.12.3 Arrow-Tech Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Arrow-Tech Personal Dosimetry Product Portfolio
    • 6.12.5 Arrow-Tech Recent Developments/Updates
  • 6.13 Renri
    • 6.13.1 Renri Corporation Information
    • 6.13.2 Renri Personal Dosimetry Description and Business Overview
    • 6.13.3 Renri Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Renri Personal Dosimetry Product Portfolio
    • 6.13.5 Renri Recent Developments/Updates
  • 6.14 RadPro International GmbH
    • 6.14.1 RadPro International GmbH Corporation Information
    • 6.14.2 RadPro International GmbH Personal Dosimetry Description and Business Overview
    • 6.14.3 RadPro International GmbH Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 RadPro International GmbH Personal Dosimetry Product Portfolio
    • 6.14.5 RadPro International GmbH Recent Developments/Updates
  • 6.15 Dosimetrics
    • 6.15.1 Dosimetrics Corporation Information
    • 6.15.2 Dosimetrics Personal Dosimetry Description and Business Overview
    • 6.15.3 Dosimetrics Personal Dosimetry Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Dosimetrics Personal Dosimetry Product Portfolio
    • 6.15.5 Dosimetrics Recent Developments/Updates

7 Personal Dosimetry Manufacturing Cost Analysis

  • 7.1 Personal Dosimetry Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Personal Dosimetry
  • 7.4 Personal Dosimetry Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Personal Dosimetry Distributors List
  • 8.3 Personal Dosimetry Customers

9 Personal Dosimetry Market Dynamics

  • 9.1 Personal Dosimetry Industry Trends
  • 9.2 Personal Dosimetry Growth Drivers
  • 9.3 Personal Dosimetry Market Challenges
  • 9.4 Personal Dosimetry Market Restraints

10 Global Market Forecast

  • 10.1 Personal Dosimetry Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Personal Dosimetry by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Personal Dosimetry by Type (2022-2027)
  • 10.2 Personal Dosimetry Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Personal Dosimetry by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Personal Dosimetry by Application (2022-2027)
  • 10.3 Personal Dosimetry Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Personal Dosimetry by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Personal Dosimetry by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    TLD
    OSL
    RPL
    Active Type

    Segment by Application
    Medical
    Scientific Research
    Industrial and Nuclear Plant
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Landauer
    Chiyoda Technol Corporation
    Mirion Technologies
    Thermo Fisher Scientific
    Fuji Electric
    Hitachi Aloka
    Bertin Instruments
    Tracerco
    ATOMTEX
    Ludlum Measurements
    XZ LAB
    Arrow-Tech
    Renri
    RadPro International GmbH
    Dosimetrics

    Buy now